Use of Immune Modulators in Patients Being Started on Anti-TNFs

Dan Joseph Stein; Salina Faidhalla

doi:10.1007/978-3-031-48949-5_40

Related publications

Article2009

Cholangiocytes as immune modulators in rotavirus‐induced murine biliary atresia

Peter J Barnes, Rebecca M. Tucker, Fabian Wehrmann, Doug G. Mack, Yoshiyuki Ueno, Cara L. Mack

Article2006

Update on the use of ciclosporin in immune-mediated dermatoses

Christopher Em Griffiths, A. Katsambas, B.A.C. Dijkmans, A.Y. Finlay, Vincent Ho, A. E. Johnston, Thomas A. Luger, Ulrich Mrowietz, Kristian Thestrup‐Pedersen

Article2023

Oral anti-coagulants use in Chinese hospitalized patients with atrial fibrillation

Jing Lin, Deyong Long, Chenxi Jiang, Caihua Sang, Ribo Tang, Songnan Li, Wei Wang, Xueyuan Guo, Man Ning, Zhaoqing Sun, Na Yang, Yongchen Hao, Jun Liu, Jing Liu, Xin Du, Louise Morgan, Gregg C. Fonarow, Sidney C. Smith, Professor Gregory Lip, Dong Zhao, Jianzeng Dong, Changsheng Ma

Article2017

Differences in immune profiles of metastatic melanoma patients treated with anti-CTLA-4 and anti-PD-1 combined immunotherapy.

Tuba N. Gide, Camelia Quek, Jason Madore, Alexander M. Menzies, Rebecca Dent, Matteo S. Carlino, Alex Guminski, Robyn P.M. Saw, John F. Thompson, James S. Wilmott, Richard A Scolyer, Georgina V. Long

Article1991

[Anti-tumor immune response in patients with colorectal carcinoma. Pre- and postoperative evaluation].

F Brivio, P. Lissoni, Rossi Gm, Aldo Maggioni, Patrizia De Marzi, Maria Colzani, D Massimini, F Ariasi, Giardini, Annalisa Angelini